Search Results for 'stroke warfarin'
stroke warfarin published presentations and documents on DocSlides.
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Watchman II: PROTECT AF/PREVAIL
by sherrill-nordquist
Meta-Analysis and Implications . David R. Holmes,...
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
The Canadian Journal of CME June 2003
by evans
atrophiclichen sclerosusWhat is the difference bet...
Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia
by adah
NOAC vs Warfarin Atrial Fibrillation Studies – A...
WATCHMANâ„¢ Left Atrial Appendage Closure Device
by alexa-scheidler
www.watchmandevice.com. AF is a Growing Problem A...
A Cost Analysis of Bleed Complications from Two Stroke Prev
by giovanna-bartolotta
valvular. Atrial Fibrillation. :. Left Atrial Ap...
LAA Closure Devices: Protecting Against Stroke
by debby-jeon
Moderator. Ted E. Feldman, MD. Director. Cardiac ...
ANTICOAGULATION Blake Wachter
by olivia-moreira
, MD, PhD . Monday Morning Conference. Oct 4, 201...
Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know
by dsuser1
Christopher Granger, . MD. Sean Pokorney, MD. . D...
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
by tatiana-dople
www.onlinecjc.com. ). . Â . If your reuse request...
Management of atrial fibrillation
by myesha-ticknor
Mary N. Healy, MS, ARNP-BC. Heart & Vascular ...
Pharmacologic and Nonpharmacologic Treatments of Atrial Fibrillation
by kittie-lecroy
Martha Drake MS, FNP-BC. Chicago Heart and Vascul...
Management of atrial fibrillation
by pamella-moone
Mary N. Healy, MS, ARNP-BC. Heart & Vascular ...
Oral anticoagulants in the 21
by natalia-silvester
st. century: A practical guide to using newer A...
Percutaneous Closure of the Left Atrial Appendage
by cheryl-pisano
versus Warfarin Therapy for Prevention of Stroke ...
Cost effectiveness of AF monitoring strategies in a
by wang
post-stroke population. Lauren E. . Cipriano. Jeff...
Treatment Options for Stroke Prevention in Nonvalvular Atri
by min-jolicoeur
Percutaneous. Left Atrial Appendage (LAA) Exclus...
Watchman I: First Report of the 5-Year PROTECT-AF and Exten
by debby-jeon
Vivek Y. Reddy, MD. Helmsley Trust Professor of M...
Digoxin And Mortality in Patients With Atrial Fibrillation
by ellena-manuel
Renato D. Lopes, MD, . PhD, FACC. on behalf of th...
Stroke or systemic embolic events in large NOAC trials, vs
by faustina-dinatale
Ruff . et al. ., The Lancet, 2013. Ruff . et al. ...
Management of Atrial Fibrillation, Stroke, and Bleeding
by natalia-silvester
Meta-Analysis of NOACs vs Warfarin. RCT vs Real-W...
What are the advantages to taking a DOAC Traditional anticoagulants su
by carla
What are Direct-Acting Oral Anticoagulants DOACsAN...
